Design and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity

Immune-checkpoint blockades, suchas PD-1 monoclonal antibodies, have shown new promising avenues to treat cancers. Failure responsesof many cancer patients to these agents have led to a massive need for alternative strategies to optimize tumor immunotherapy. Currently, new therapeutic developments i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Abdul Baset, Lin, Bingjing, Liu, Chen, Morshed, Arwa, Hu, Jialiang, Xu, Hanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386944/
https://www.ncbi.nlm.nih.gov/pubmed/30699956
http://dx.doi.org/10.3390/ijms20030572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386944/
https://www.ncbi.nlm.nih.gov/pubmed/30699956
http://dx.doi.org/10.3390/ijms20030572

Ejemplares similares